Article Information
History
- August 8, 2021.
Article Versions
- You are currently viewing Version 1 of this article (August 8, 2021 - 11:13).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kento T. Abe1,2,*,
- Queenie Hu1,*,
- Mohammad Mozafarihashjin1,3,*,
- Reuben Samson1,2,
- Kathy Manguiat4,
- Alyssia Robinson4,
- Bhavisha Rathod1,
- Jenny H. Wang1,
- Mariam Iskilova1,
- Adrian Pasculescu1,
- Mahya Fazel-Zarandi1,
- Angel Li3,
- Aimee Paterson3,
- Gary Chao5,
- Karen Green3,
- Lois Gilbert1,3,
- Shiva Barati1,3,
- Nazrana Haq1,3,
- Alyson Takaoka3,4,5,6,
- Julia Garnham Takaoka3,4,5,6,
- Keelia Quinn De Launay3,6,
- Christine Fahim6,
- Salma Sheikh-Mohamed5,
- Yuko Arita7,
- Yves Durocher8,
- Eric G. Marcusson7,9,
- Jennifer L. Gommerman5,
- Mario Ostrowski4,6,10,
- Karen Colwill1,
- Sharon E. Straus6,10,
- Heidi Wood4,
- Allison J. McGeer1,3,11,** and
- Anne-Claude Gingras1,2,**
- 1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
- 2Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
- 3Department of Microbiology, at Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada
- 4National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MN, Canada
- 5Department of Immunology, University of Toronto, Toronto, ON, Canada
- 6Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON, Canada
- 7Providence Therapeutics Holdings, Inc.; Calgary, Alberta, Canada
- 8Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada
- 9Marcusson Consulting, San Francisco, CA, USA
- 10Department of Medicine, University of Toronto, Toronto, ON, Canada
- 11Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
- ↵**correspondence to: Allison J. McGeer (Allison.McGeer{at}sinaihealth.ca), 600 University Ave, Rm 210, Toronto, ON, M5G1X5; T.416-586-3118, or Anne-Claude Gingras (gingras{at}lunenfeld.ca), 600 University Ave, Rm 982, Toronto, ON, M5G1X5; T.416-586-5027
↵* co-first authors (see author contribution)
Posted August 08, 2021.
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
